key: cord-1018924-6kj7taza
authors: Mahrokhian, Shant H.; Nordan, Taylor; Kawabori, Masashi
title: Immunosuppression in HIV Positive Heart Transplant Recipients in the post-COVID-19 era
date: 2021-07-24
journal: Ann Thorac Surg
DOI: 10.1016/j.athoracsur.2021.06.052
sha: f2849d4538aa1c274819a134e53da412cc218379
doc_id: 1018924
cord_uid: 6kj7taza

nan

Letter to the Editor:

With great interest, we read the article recently published by Doberne et al. regarding heart transplantation outcomes in HIV positive (HIV+) and negative (HIV-) recipients. 1 We commend the authors for their important work reporting no differences in survival among these two patient populations. Propensity score matching and Cox-proportional hazards modeling both supported the conclusion that HIV+ recipient status was not an independent predictor of post-transplant mortality. Additionally, HIV+ recipients experienced higher rates of acute rejection and treatment with antirejection medications prior to discharge. 

Heart Transplantation Survival Outcomes of HIV Positive and Negative Recipients

Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus

Single-shot Ad26 vaccine protects against